Home Use of Mechanical Insufflation/Exsufflation Devices in Neuromuscular Diseases
Completed
- Conditions
- Neuromuscular Diseases
- Interventions
- Device: Mechanical insufflation/exsufflation device (MI-E)
- Registration Number
- NCT04729920
- Lead Sponsor
- Centre Hospitalier Universitaire Vaudois
- Brief Summary
With this cross-sectional study of adult subjects with neuromuscular disease in the French-speaking part of Switzerland, we aim to explore MI-E adherence using self-report questionnaires and device data in order to identify the factors that influence the pattern of MI-E use and satisfaction with the treatment. Determining potential barriers to regular long-term home use of MI-E could help in identifying the patients who would benefit most from this therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 43
Inclusion Criteria
- Age over 18 years
- Diagnosis of neuromuscular disease
- Active prescription of MI-E for more than 3 months
Exclusion Criteria
-Invasive airway
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description subjects with neuromuscular disease Mechanical insufflation/exsufflation device (MI-E) Adult subjects with neuromuscular disease, with an active prescription of MI-E for more than 3 months
- Primary Outcome Measures
Name Time Method Adherence to MI-E (reported) 12 months, or since treatment initiation (> 3 months) based on self-reported use
Adherence to MI-E (objective) 12 months, or since treatment initiation (> 3 months) based on data downloads
- Secondary Outcome Measures
Name Time Method Satisfaction with the device 12 months, or since treatment initiation (> 3 months) Self-report questionnaire
Trial Locations
- Locations (1)
Service de Pneumologie, CHUV
🇨🇭Lausanne, Vaud, Switzerland